EUVIMEDEUVIMED entdecken
Open Access

Interstitial Brachytherapy for Lip Cancer: Technical Aspects to Individualize Treatment Approach and Optimize Outcomes

Emily C Merfeld, Matthew E Witek, David M Francis, Adam R Burr, Charles R Wallace, Aleksandra Kuczmarska-Haas, Narottam Lamichhane, Randall J Kimple, Tiffany A Glazer, Aaron M Wieland, Timothy M McCulloch, Gregory K Hartig und 1 weitere

Practical Radiation Oncology · 2023

DOI: 10.1016/j.prro.2023.01.004 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Practical Radiation Oncology, 2023. Verfasst von Emily C Merfeld und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Human Oncology, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin. Electronic address: emerfeld@uwhealth…. Hauptthemen laut MEDLINE: Brachytherapy, Lip Neoplasms, Carcinoma, Squamous Cell. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 14 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, National Cancer Institute, University of Wisconsin Carbone Cancer Center.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Primary radiation therapy using interstitial brachytherapy (IBT) provides excellent local tumor control for early-stage squamous cell carcinoma of the lip. Technical aspects of treatment are important to optimize outcomes. In this report, we discuss patient selection criteria, procedural details, and dosimetric considerations for performing IBT for cancers of the lip. Catheters are inserted across the length of tumor entering and exiting approximately 5 mm beyond the palpable tumor extent. A custom mouthpiece is fabricated to facilitate normal tissue sparing. Patients undergo computed tomography imaging, the gross tumor volume is contoured based on physical examination and computed tomography findings, and an individualized brachytherapy plan is generated with the goals of achieving gross tumor volume D90% ≥ 90% and minimizing V150%. Ten patients with primary (n = 8) or recurrent (n = 2) cancers of the lip who received high-dose-rate lip IBT using 2.0- to 2.5-week treatment regimens are described (median prescription: 47.6 Gy in 14 fractions of 3.4 Gy). Local tumor control was 100%. There were no cases of acute grade ≥4 or late grade ≥2 toxicity, and cosmesis scores were graded as good to excellent in all patients. IBT represents an excellent treatment option for patients with lip squamous cell carcinoma. With careful attention to technical considerations furthered described in the present report, high rates of tumor control, low rates of toxicity, and favorable esthetic and functional outcomes can be achieved with IBT for lip cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BrachytherapyLip NeoplasmsCarcinoma, Squamous CellHumansCombined Modality TherapyRadiometryRadiotherapy Dosage

Autor:innen und Institutionen

  • Department of Human Oncology, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin. Electronic address: emerfeld@uwhealth.org.
  • Department of Human Oncology, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin; Department of Radiation Oncology, University of Maryland School of Medicine, Baltimore, Maryland.
  • Department of Human Oncology, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin.
  • Department of Radiation Oncology, University of Maryland School of Medicine, Baltimore, Maryland.
  • Division of Otolaryngology-Head and Neck Surgery, Department of Surgery, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin.

Förderung

  • NCI NIH HHS
  • National Cancer Institute
  • University of Wisconsin Carbone Cancer Center
  • National Institutes of Health

Zitieren

APA

Merfeld, E. C., Witek, M. E., Francis, D. M., Burr, A. R., Wallace, C. R., Kuczmarska-Haas, A., Lamichhane, N., Kimple, R. J., Glazer, T. A., Wieland, A. M., McCulloch, T. M., Hartig, G. K., & Harari, P. M. (2023). Interstitial Brachytherapy for Lip Cancer: Technical Aspects to Individualize Treatment Approach and Optimize Outcomes. Practical Radiation Oncology. https://doi.org/10.1016/j.prro.2023.01.004

Vancouver

Merfeld EC, Witek ME, Francis DM, Burr AR, Wallace CR, Kuczmarska-Haas A, et al. Interstitial Brachytherapy for Lip Cancer: Technical Aspects to Individualize Treatment Approach and Optimize Outcomes. Practical Radiation Oncology. 2023. doi:10.1016/j.prro.2023.01.004

BibTeX
@article{Merfeld2023,
  author = {Merfeld, Emily C and Witek, Matthew E and Francis, David M and Burr, Adam R and Wallace, Charles R and Kuczmarska-Haas, Aleksandra and Lamichhane, Narottam and Kimple, Randall J and Glazer, Tiffany A and Wieland, Aaron M and McCulloch, Timothy M and Hartig, Gregory K and Harari, Paul M},
  title = {Interstitial Brachytherapy for Lip Cancer: Technical Aspects to Individualize Treatment Approach and Optimize Outcomes},
  journal = {Practical Radiation Oncology},
  year = {2023},
  doi = {10.1016/j.prro.2023.01.004}
}
Kostenlos starten →